In Europe, approximately 30 million people are affected by one of the more than 6,000 known rare diseases. In Austria, there are 400,000 people who have been diagnosed with a rare disease.
If you are looking for the MPN-netzwerk.com page, please follow this link
According to the Austrian Medicines Act (AMG), we are obliged to provide information about prescription drugs as well as medical information exclusively to medical experts and only in the password-protected area.
Log in with your DocCheck account right now and get access to the expert content!
More Information about DocCheck Log in (only in German) here
What are Myeloproliferative neoplasms (MPN)?
Myeloproliferative neoplasms (MPN), previously called myeloproliferative disorders, are a group of chronic diseases of the blood-forming cells in the bone marrow.
What is polycythaemia vera?
Polycythaemia vera (PV) is a chronic disease of the blood-producing cells in the bone marrow. It results in an overproduction of the blood cells that above all affects the red blood cells (erythrocytes).
What is essential Thrombocythaemia?
Essential thrombocythaemia (ET) is a disease of the bone marrow, characterised by a pronounced increase of the number of platelets (thrombocytes) in the blood.
What is primary myelofibrosis?
Primary myelofibrosis (PMF) is a rare, chronic disorder in which the development of fibrosis in the bone marrow interferes with blood cell production, which can lead to anaemia, bleeding, and enlargement of the spleen and liver.
MPN meetings for patients
Ask an Expert (only in German)
Experts answer your questions about the disease polycythaemia vera.
Only in GERMAN
SAVE the DATE:
Patient Consultation Hour
on 29 February 2024
5 to 7pm
Webcast - MPN Awareness Month September
Young Patients Talks
Webcast - MPN Breakfast 2023
On the occasion of the 11th Annual MPN Awareness Day we invited to our traditional MPN Breakfast, a panel discussion with patient advocates, health care professionals and industry representatives, focusing on the topic “Manager of your own disease – benefits & challenges”.